Literature DB >> 30455098

Frequency of Testing for Prostate Cancer Using Prostate-Specific Antigen Among Older Men in a Large Health System.

Theresa A Rowe, Ji Young Lee, Joshua J Meeks, Stephen D Persell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30455098      PMCID: PMC6522328          DOI: 10.1016/j.jcjq.2018.10.003

Source DB:  PubMed          Journal:  Jt Comm J Qual Patient Saf        ISSN: 1553-7250


× No keyword cloud information.
  5 in total

1.  Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals.

Authors:  E A Platz; E B Rimm; W C Willett; P W Kantoff; E Giovannucci
Journal:  J Natl Cancer Inst       Date:  2000-12-20       Impact factor: 13.506

2.  Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study.

Authors:  Richard M Hoffman; Michael J Barry; Janet L Stanford; Ann S Hamilton; William C Hunt; Mary McNaughton Collins
Journal:  Am J Med       Date:  2006-05       Impact factor: 4.965

3.  National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.

Authors:  Michael W Drazer; Sandip M Prasad; Dezheng Huo; Mara A Schonberg; William Dale; Russell Z Szmulewitz; Scott E Eggener
Journal:  Cancer       Date:  2014-02-12       Impact factor: 6.860

4.  Why do general practitioners prescribe antibiotics for upper respiratory tract infections to meet patient expectations: a mixed methods study.

Authors:  Stephanie Fletcher-Lartey; Melissa Yee; Christina Gaarslev; Rabia Khan
Journal:  BMJ Open       Date:  2016-10-24       Impact factor: 2.692

5.  Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa.

Authors:  Titilola O Akinremi; Frank Chinegwundoh; Robin Roberts; Daohai Yu; R Renee Reams; Matthew L Freedman; Brian Rivers; B Lee Green; Folakemi T Odedina; Nagi Kumar
Journal:  Infect Agent Cancer       Date:  2009-02-10       Impact factor: 2.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.